| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |